TrialEuropean journal of neurology2018

Tafamidis delays neurological progression comparably across Val30Met and non-Val30Met genotypes in transthyretin familial amyloid polyneuropathy.

B K Gundapaneni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.